Dentsply Sirona, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US24906P1093
USD
11.27
0.16 (1.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Dentsply Sirona, Inc. stock-summary
stock-summary
Dentsply Sirona, Inc.
Pharmaceuticals & Biotechnology
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company operates in two operating segments: Technologies & Equipment, and Consumables. The Technologies & Equipment segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. It also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
Company Coordinates stock-summary
Company Details
13320 Ballantyne Corporate Pl , CHARLOTTE NC : 28277-3607
stock-summary
Tel: 1 717 84575111 717 8497863
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 106 Schemes (73.7%)

Foreign Institutions

Held by 250 Foreign Institutions (18.21%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Eric Brandt
Non-Executive Independent Chairman of the Board
Mr. Donald Casey
Chief Executive Officer, Director
Mr. Clyde Hosein
Director
Dr. Michael alfano
Independent Director
Mr. Willie Deese
Independent Director
Ms. Betsy Holden
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
936 Million
(Quarterly Results - Jun 2025)
Net Profit:
-44 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3,487 Million (Small Cap)

stock-summary
P/E

22.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

196.12%

stock-summary
Debt Equity

1.04

stock-summary
Return on Equity

17.95%

stock-summary
Price to Book

1.78